Interesting solutions for Gynecologist to get better healing results using pure biology
Obstetrics and Gynecology: Faster healing and less adhesion
The A-PRF™ membranes provide the surgeon with access to the patients immune system and growth factors concentrated at the surgical site stimulating the processes of the healing cascade in various ways – advancing healing.
Read more about A-PRF™
i-PRF™ is the next step PRF and offers the characteristics of A-PRF™ as a liquid. On top i-PRF™ capture an amount of stemcells from the blood stream.
Read more about i-PRF™
Hyacorp Endo Gel® is a carefully designed product which provides the ultimate solution for post operative adhesions prevention, used by Surgery, Gynecology, Orthopedic doctors during any surgical related procedures to assure the best surgical practice with prevention of adhesions formation that causes a post-operative pain, infertility, bowel obstruction, restriction of movement in case of tendon and spinal surgery.
Advanced Platelet Rich Fibrin solutions
Faster healing based on the patients healing capacity – leucocytes and growth factors
Cross-linked Hyaluronic Acid
Less adhesion problems when using HyaCorp endo gel®
HyaCorp endo gel® is a bio-absorbable, transparent gel composed of cross-linked hyaluronic acid. The viscous nature of Hyacorp endo gel allows it to effectively adhere to the tissue surface and to the abdominal wall, creating an anti-adhesion barrier which keeps the adjacent tissue separated during the repair phase subsequent to a surgical procedure. The gel is completely degraded following the natural pathway of hyaluronan, within seven days after the application.
Article: Effect of cross linked sodium hyaluronate in adhesion reduction within the gynecologic surgical window
Conclusions and Discussion: Fibrous adhesions between pelvic organs and the pelvic side wall during gynecological surgical procedures with laparoscopy cause severe pain and further burden the task of the laparoscopic surgeon. The attempt to reduce these adhesions by applying the site specific, hyaloronic acid based barrier, Hya-Corp endogel’ proved to be satisfying and helpful in this purely observational study.
Open Journal of Obstetrics and Gynecology, 2014, 4, 120-129 OJOG http://dx.doi.org/10.4236/ojog.2014.43022 Published Online February 2014 (http://www.scirp.org/journal/ojog/)